# OnCo record skopos-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/skopos-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "skopos-bio" ;
  schema:name "Skopos Bio"@en ;
  schema:description "Skopos Bio is a Melbourne spin-out from the Peter MacCallum Cancer Centre developing radioactive drugs that home in on cancer cells, including targets ordinary drugs struggle to reach. It launched in October 2026 with seed funding to reach first human trials."@en ;
  schema:url <https://onco.cc/companies/skopos-bio/>, <https://www.skoposbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.skoposbio.com/>, <https://smartcompany.com.au/startupsmart/three-aussie-startups-that-raised-18-75-million-this-week> ;
  schema:addressCountry "AU" ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> .